Federal Circuit Patent Updates - May 2017

WilmerHale
Contact

In re Affinity Labs of Texas, LLC (No. 2016-1092, -1172, 5/5/17) (Taranto, Chen, Stoll)

May 5, 2017 3:19 PM

Chen, J. The estoppel provision of pre-AIA section 317(b) did not serve as a bar to maintain an inter partes reexamination where district court invalidity claims had been dismissed without prejudice. On the merits, affirming claim construction under broadest reasonable interpretation standard. 

A full version of the text is available in PDF form.

In re Affinity Labs of Texas, LLC (No. 2016-1173, 5/5/17) (Taranto, Chen, Stoll)

May 5, 2017 12:10 PM

Chen, J. The estoppel provision of pre-AIA section 317(b) did not serve as a bar to maintain inter partes reexaminations with respect to claims that were not subject to district court judgment or against parties that were not part of the judgment or with respect to a consolidated ex parte reexamination. 

A full version of the text is available in PDF form.

Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc. (No. 2016-1284, -1787, 5/1/17) (Dyk, Mayer, O'Malley)

May 1, 2017 9:41 AM

Dyk, J. Reversing district court holding in Hatch-Waxman case that four patents (one of which was governed by the AIA and three of which were not) were not invalid under on-sale bar. With respect to the pre-AIA patents, an agreement for the sale of goods contingent on regulatory approval constitutes a commercial sale. With respect to the post-AIA patent, “We conclude that, after the AIA, if the existence of the sale is public, the details of the invention need not be publicly disclosed in the terms of sale.” The invention was “ready for patenting” because it was reduced to practice prior to the critical date. 

A full version of the text is available in PDF form.

 

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations. Attorney Advertising.

© WilmerHale

Written by:

WilmerHale
Contact
more
less

PUBLISH YOUR CONTENT ON JD SUPRA NOW

  • Increased visibility
  • Actionable analytics
  • Ongoing guidance

WilmerHale on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide